{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Assessed by Kaplan-Meier survival analysis and 95% confidence intervals will be calculated using Greenwood's formulae.","groups":[{"description":"Patients receive aflibercept IV over 1 hour on day 1. Treatment repeats every 2 weeks for up to 6 courses in the absence of disease progression or unacceptable toxicity.\n\naflibercept: Given IV","id":"OG000","title":"Treatment (Antiangiogenesis Therapy)"}],"populationDescription":"Overall survival was not assessed by the Kaplan-Meier survival or calculated using the Greenwood's formulae.","reportingStatus":"POSTED","timeFrame":"Time from first treatment day until death, assessed up to 6 months","title":"Overall Survival (OS)","type":"SECONDARY"}